Workflow
Aclaris Therapeutics (NasdaqGS:ACRS) 2025 Earnings Call Presentation

Patient Focused Innovation Developing Therapeutic Franchises to Address Gaps in Important I&I Diseases Tradenames, trademarks and service marks of other companies appearing in this presentation are the property of their respective owners. All future development, clinical, and regulatory timelines are expectations, are based on current beliefs and assumptions, and are subject to change based on a variety of factors. 2 Today's Agenda Patient Focused Innovation 2025 R&D Day October 14, 2025 Disclaimer and Caut ...